Sanofi India: Strong balance sheet, high cash reserves positives for stock
Products in the price control list and growth of the non-power brand portfolio will be key monitorables05-05-2022
05-05-2022
Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has approved issue of duplicate share certificates requests in lieu of the original share certificates reported lost/misplaced, details of which are enclosed.29-04-2022
Hold Sanofi India; target of Rs 7740: ICICI Direct
ICICI Direct recommended hold rating on Sanofi India with a target price of Rs 7740 in its research report dated April 27, 2022.29-04-2022
Sanofi India Ltd - 500674 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Sanofi India Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here28-04-2022
Sanofi India Ltd - 500674 - Postal Ballot Notice - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')
In terms of Regulation 30 of the SEBI Listing Regulations, we hereby inform that the Board of Directors at its meeting held on 26th April 2022, approved conducting of Postal Ballot for seeking the approval of members for appointment of Mr. Rodolfo Hrosz as Managing Director of the Company w.e.f 1st June 2022 by passing an Ordinary Resolution. The Board of Directors have also appointed Mr. Makarand M. Joshi, Partner or failing him Ms. Kumudini Bhalerao, Partner at M/s Makarand M. Joshi & Co., Practicing Company Secretaries, who have given the consent to act as the Scrutinizer, for conducting the Postal Ballot process. The Company shall further intimate the Stock Exchanges on dispatch of the Postal Ballot notice. The Calendar of Events for the proposed postal ballot process is attached for your reference27-04-2022
Sanofi India Ltd - 500674 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Please find enclosed the Scrutinizer's Report issued by M/s. Makarand M Joshi & Co., Company Secretaries on the remote e-voting conducted from 22nd April 2022 to 25th April 2022 and e-voting at the Annual General Meeting held on 26th April 2022.27-04-2022
Buy Sanofi India: target of Rs 9250: Sharekhan
Sharekhan is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 9250 in its research report dated April 26, 2022.27-04-2022
Sanofi India Ltd - 500674 - Summary Of Proceedings Of 66Th Annual General Meeting
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a summary of proceedings of the 66th Annual General Meeting of the Company held on 26th April 2022 through video conferencing facility. Please take the above information on record.27-04-2022
Sanofi India Ltd - 500674 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended 31St March 2022
We refer to our letter dated 7th April 2022 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 12.00 noon and concluded at 2.15 p.m. The Board approved unaudited financial results for the quarter ended 31st March 2022. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a copy of the unaudited financial results for the quarter ended 31st March 2022 approved at this Meeting along with a copy of the Limited Review Report for your information. Please take the above information on record26-04-2022
Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed.21-04-2022